Value of Radionuclide Cisternography
VERTICAL
VALUE OF RADIONUCLIDE CISTERNOGRAPHY IN PATIENTS WITH CEREBROSPINAL FLUID LEAK
1 other identifier
observational
113
0 countries
N/A
Brief Summary
Radionuclide cisternography (RC) is a nuclear medicine examination based on intrathecal injection of \[111In\]diethylenetriaminepentaacetic acid (\[111In\]DTPA). It is prescribed for two recommendations: detection of cerebrospinal fluid (CSF) leak/fistula and diagnosis of normal pressure hydrocephalus. In the search part of CSF leak/fistula, RC offers the benefit of a 24-hour study of CSF unlike other reference tests. In addition to SPECT/CT imaging, the radiopharmacist performs sampling in nasal cavities and throat of the patient to collect a possible flow of CSF. These samples are analysed by radioactivity measurements and bring an added value to the exam. The interest of this examination for management of CSF leak/fistula remains unclear. The aim of this study is to identify and analyse results of all RC examinations performed since 2005 in the Nuclear Medicine department of the Neurological Hospital. The full analysis of patients will allow discussing the role of RC in management of CSF leak/fistulae in clinical practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2005
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2005
CompletedFirst Submitted
Initial submission to the registry
August 9, 2016
CompletedFirst Posted
Study publicly available on registry
August 24, 2016
CompletedAugust 24, 2016
August 1, 2016
11 months
August 9, 2016
August 18, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
RC /SPECT/CT imaging
Results of RC including results of SPECT/CT imaging and results of swabs counting (nasal cavities and throat or ear if applicable)
one week
Eligibility Criteria
patients who received a convocation for realization of RC
You may qualify if:
- patients who received a convocation for realization of RC (extraction with GERA, software of Nuclear Medicine)
You may not qualify if:
- patients who received a convocation for realization of RC with "valve" protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elise LEVIGOUREUX, MD
Hospices Civils de Lyon
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 9, 2016
First Posted
August 24, 2016
Study Start
January 1, 2005
Primary Completion
December 1, 2005
Study Completion
December 1, 2005
Last Updated
August 24, 2016
Record last verified: 2016-08
Data Sharing
- IPD Sharing
- Will not share